Humedix Co Ltd (200670) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.037x

Based on the latest financial reports, Humedix Co Ltd (200670) has a cash flow conversion efficiency ratio of 0.037x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩9.71 Billion ≈ $6.58 Million USD) by net assets (₩265.23 Billion ≈ $179.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Humedix Co Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Humedix Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Humedix Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Humedix Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Humedix Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kogan.com Ltd AU:KGN	-0.163x
Profound Medical Corp TO:PRN	-0.100x
SIM Acquisition Corp. I Class A Ordinary Shares NASDAQ:SIMA	0.000x
Polyram Plastic Industries Ltd TA:POLP	0.072x
Metro Mining Limited F:6ME	-0.116x
Luca Mining Corp. V:LUCA	N/A
CERRO DE PASCO RES F:N8HP	N/A
Shandong Longertek Technology Co Ltd SHE:300594	0.079x

Annual Cash Flow Conversion Efficiency for Humedix Co Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of Humedix Co Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see 200670 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩228.53 Billion ≈ $154.87 Million	₩50.74 Billion ≈ $34.39 Million	0.222x	+42.39%
2023-12-31	₩198.06 Billion ≈ $134.22 Million	₩30.89 Billion ≈ $20.93 Million	0.156x	-43.14%
2022-12-31	₩139.11 Billion ≈ $94.27 Million	₩38.15 Billion ≈ $25.86 Million	0.274x	+80.11%
2021-12-31	₩125.99 Billion ≈ $85.38 Million	₩19.18 Billion ≈ $13.00 Million	0.152x	-23.06%
2020-12-31	₩120.07 Billion ≈ $81.37 Million	₩23.76 Billion ≈ $16.10 Million	0.198x	+60.66%
2019-12-31	₩112.10 Billion ≈ $75.97 Million	₩13.81 Billion ≈ $9.36 Million	0.123x	-45.07%
2018-12-31	₩106.13 Billion ≈ $71.93 Million	₩23.80 Billion ≈ $16.13 Million	0.224x	+176.11%
2017-12-31	₩107.92 Billion ≈ $73.13 Million	₩8.77 Billion ≈ $5.94 Million	0.081x	+16.47%
2016-12-31	₩109.11 Billion ≈ $73.94 Million	₩7.61 Billion ≈ $5.16 Million	0.070x	-34.59%
2015-12-31	₩109.80 Billion ≈ $74.41 Million	₩11.71 Billion ≈ $7.93 Million	0.107x	--

About Humedix Co Ltd

KQ:200670 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$246.43 Million

₩363.63 Billion KRW

Market Cap Rank

#15744 Global

#616 in Korea

Share Price

₩35350.00

Change (1 day)

-3.81%

52-Week Range

₩31950.00 - ₩75800.00

All Time High

₩75800.00